Legal & General Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$698M Sell
2,363,927
-117,396
-5% -$34.9M 0.16% 110
2025
Q4
$678M Buy
2,481,323
+44,252
+2% +$12M 0.15% 116
2025
Q3
$658M Buy
2,437,071
+124,820
+5% +$34M 0.15% 119
2025
Q2
$637M Buy
2,312,251
+225,449
+11% +$61.3M 0.16% 120
2025
Q1
$554M Buy
2,086,802
+45,353
+2% +$11.2M 0.15% 128
2024
Q4
$474M Sell
2,041,449
-90,426
-4% -$20.8M 0.13% 152
2024
Q3
$470M Sell
2,131,875
-49,475
-2% -$10.2M 0.12% 160
2024
Q2
$429M Buy
2,181,350
+50,495
+2% +$10.4M 0.12% 156
2024
Q1
$459M Sell
2,130,855
-4,071
-0.2% -$855K 0.13% 150
2023
Q4
$450M Sell
2,134,926
-20,891
-1% -$4.46M 0.14% 142
2023
Q3
$432M Sell
2,155,817
-92,004
-4% -$18.3M 0.15% 135
2023
Q2
$416M Buy
2,247,821
+32,846
+1% +$6.07M 0.14% 151
2023
Q1
$424M Buy
2,214,975
+32,532
+1% +$5.88M 0.15% 141
2022
Q4
$367M Sell
2,182,443
-187,869
-8% -$32.6M 0.14% 161
2022
Q3
$420M Sell
2,370,312
-117,332
-5% -$23.2M 0.16% 128
2022
Q2
$509M Buy
2,487,644
+159,962
+7% +$33.9M 0.18% 111
2022
Q1
$554M Buy
2,327,682
+144,726
+7% +$34M 0.17% 119
2021
Q4
$499M Sell
2,182,956
-116,183
-5% -$25.6M 0.15% 132
2021
Q3
$445M Buy
2,299,139
+87,913
+4% +$17.8M 0.14% 147
2021
Q2
$470M Sell
2,211,226
-56,571
-2% -$11.9M 0.16% 133
2021
Q1
$463M Sell
2,267,797
-12,304
-0.5% -$2.42M 0.17% 120
2020
Q4
$415M Buy
2,280,101
+28,411
+1% +$4.83M 0.16% 130
2020
Q3
$377M Sell
2,251,690
-39,583
-2% -$6.67M 0.17% 130
2020
Q2
$372M Buy
2,291,273
+105,420
+5% +$18.9M 0.18% 120
2020
Q1
$378M Buy
2,185,853
+54,775
+3% +$10.9M 0.22% 94
2019
Q4
$428M Buy
2,131,078
+29,666
+1% +$6.09M 0.2% 106
2019
Q3
$444M Sell
2,101,412
-16,629
-0.8% -$3.47M 0.23% 88
2019
Q2
$411M Sell
2,118,041
-29,538
-1% -$5.45M 0.22% 96
2019
Q1
$353M Buy
2,147,579
+331,439
+18% +$58.6M 0.2% 107
2018
Q4
$342M Buy
1,816,140
+203,486
+13% +$37.6M 0.26% 79
2018
Q3
$275M Buy
1,612,654
+34,772
+2% +$5.85M 0.2% 116
2018
Q2
$259M Sell
1,577,882
-88,694
-5% -$14.5M 0.2% 119
2018
Q1
$269M Sell
1,666,576
-227,930
-12% -$36.3M 0.21% 109
2017
Q4
$277M Buy
1,894,506
+193,726
+11% +$27.6M 0.2% 117
2017
Q3
$231M Buy
1,700,780
+60,352
+4% +$7.62M 0.17% 137
2017
Q2
$205M Buy
1,640,428
+91,333
+6% +$10.9M 0.17% 145
2017
Q1
$184M Buy
1,549,095
+54,353
+4% +$6.54M 0.16% 154
2016
Q4
$172M Buy
1,494,742
+19,608
+1% +$2.18M 0.16% 150
2016
Q3
$154M Buy
1,475,134
+24,999
+2% +$2.61M 0.16% 157
2016
Q2
$141M Buy
1,450,135
+58,653
+4% +$5.54M 0.15% 163
2016
Q1
$134M Buy
1,391,482
+27,322
+2% +$2.49M 0.15% 161
2015
Q4
$124M Buy
1,364,160
+13,214
+1% +$1.24M 0.14% 166
2015
Q3
$125M Buy
1,350,946
+55,152
+4% +$5.24M 0.15% 160
2015
Q2
$121M Buy
+1,295,794
New +$121M 0.14% 174

Other funds holding CME

Legal & General Group's CME Position: Q1 2026 in Review

Legal & General Group reduced its CME Group (CME) stake by 4.7% in Q1 2026, selling an estimated $34.9M and leaving 2,363,927 shares worth $698M. The position accounts for 0.16% of the portfolio, ranked #110.

Legal & General Group first reported a position in CME in Q2 2015 and has held it in 44 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Legal & General Group held 2,363,927 shares of CME Group worth $698M as of Q1 2026.
  • Legal & General Group sold 117,396 CME Group shares in Q1 2026, an estimated $34.9M.
  • CME Group made up 0.16% of Legal & General Group's portfolio in Q1 2026, its #110 holding.
  • Legal & General Group first reported a position in CME Group in Q2 2015 and has held it in 44 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.